The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men.
暂无分享,去创建一个
O. Raitakari | M. Koskenvuo | I. Huhtaniemi | K. Irjala | F. Saad | P. Pöllänen | J. Mäkinen | M. Oettel | D. Hübler | K. Härkönen
[1] I. Thompson,et al. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. , 2002, The Journal of urology.
[2] A. Araujo,et al. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men , 2001, Biological Psychiatry.
[3] S. Roose,et al. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. , 2001, The Journal of clinical psychiatry.
[4] D. Lamb,et al. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. , 2001, Fertility and sterility.
[5] E. Rimm,et al. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. , 2000, Journal of the National Cancer Institute.
[6] F. Comhaire,et al. Andropause: Hormone Replacement Therapy in the Ageing Male , 2000, European Urology.
[7] J. Kaprio,et al. Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. , 2000, American journal of epidemiology.
[8] J. Benichou,et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. , 2000, Cancer research.
[9] I. Kanazawa,et al. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription , 2000, Nature Genetics.
[10] R. Rosenfield,et al. Role of hormones in pilosebaceous unit development. , 2000, Endocrine reviews.
[11] P. Andersen,et al. Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia , 2000, European Journal of Human Genetics.
[12] J. Favaloro,et al. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. , 2000, Journal of molecular endocrinology.
[13] H. Perry,et al. Androgen deficiency in aging men: role of testosterone replacement therapy. , 2000, The Journal of laboratory and clinical medicine.
[14] J. L. San Millán,et al. The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. , 2000, The Journal of clinical endocrinology and metabolism.
[15] G. Coetzee,et al. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. , 2000, Human molecular genetics.
[16] M. Hüfner,et al. Psychoendocrine sequelae of chronic testosterone deficiency. , 1999, Journal of psychiatric research.
[17] A. Trounson,et al. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene , 1999, The Lancet.
[18] Chawnshang Chang,et al. The Linkage of Kennedy’s Neuron Disease to ARA24, the First Identified Androgen Receptor Polyglutamine Region-associated Coactivator* , 1999, The Journal of Biological Chemistry.
[19] J B McKinlay,et al. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. , 1999, The Journal of endocrinology.
[20] G. Chrousos,et al. Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. , 1999, The Journal of clinical endocrinology and metabolism.
[21] E. Barrett-Connor,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study , 2022 .
[22] A. Shalita,et al. Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne , 1998, Journal of cutaneous medicine and surgery.
[23] J. Rabkin,et al. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. , 1998, Journal of affective disorders.
[24] F. Ghadessy,et al. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. , 1997, The Journal of clinical endocrinology and metabolism.
[25] S. Piantadosi,et al. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] P J Garry,et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. , 1997, Metabolism: clinical and experimental.
[27] P. Kantoff,et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Coetzee,et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. , 1997, Journal of the National Cancer Institute.
[29] H. Scher,et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. , 1996, The Journal of clinical endocrinology and metabolism.
[30] H. Nakajima,et al. Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy , 1996, Journal of the Neurological Sciences.
[31] L Pinsky,et al. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. , 1995, Human molecular genetics.
[32] G. Jenster,et al. Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. , 1994, Biochemistry.
[33] N. Chamberlain,et al. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. , 1994, Nucleic acids research.
[34] R. Legro,et al. Size Polymorphisms of the Androgen Receptor Among Female Hispanics and Correlation With Androgenic Characteristics , 1994, Obstetrics and gynecology.
[35] G. Rouleau,et al. Reduced transcriptional regulatory competence of the androgen receptor in X–linked spinal and bulbar muscular atrophy , 1993, Nature genetics.
[36] K. Tennekoon,et al. Serum FSH, LH, and testosterone concentrations in presumably fertile men: effect of age. , 1993, International journal of fertility.
[37] L. Jin,et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. , 1992, Genomics.
[38] J. Mckinlay,et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. , 1991, The Journal of clinical endocrinology and metabolism.
[39] K. Fischbeck,et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.
[40] J. Kaufman,et al. Neuroendocrine regulation of pulsatile luteinizing hormone secretion in elderly men , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[41] S. S. Davis,et al. Secondary hypogonadism in older men: its relation to impotence. , 1990, The Journal of clinical endocrinology and metabolism.
[42] T. Nagashima,et al. Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome) Autopsy case report of two brothers , 1988, Journal of the Neurological Sciences.
[43] S. S. Davis,et al. Impotence and Aging: Clinical and Hormonal Factors , 1988, Journal of the American Geriatrics Society.
[44] J. Yesavage,et al. Plasma testosterone levels, depression, sexuality, and age , 1985, Biological Psychiatry.
[45] J. Santamaria,et al. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure , 1983, Journal of the Neurological Sciences.
[46] J. Wieland,et al. Impaired Leydig cell reserve and altered serum androgen binding in the aging male. , 1976, Fertility and sterility.
[47] A. Klibanski,et al. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. , 2000, The Journal of clinical endocrinology and metabolism.
[48] P. Kantoff,et al. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. , 1999, Urology.
[49] T. Zimmermann,et al. A new ‘aging males’ symptoms' rating scale , 1999 .
[50] J. Deslypere,et al. A new look to the andropause: altered function of the gonadotrophs. , 1989, Journal of steroid biochemistry.
[51] J. Kaufman,et al. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. , 1987, The Journal of clinical endocrinology and metabolism.